New appointment at iPierian
This article was originally published in Scrip
iPierian, a California-based biopharmaceutical firm, has appointed Dr Michael Venuti as president and chief scientific officer. Dr Venuti has 25 years of experience and is charged with establishing large-scale discovery and development collaborations to help iPierian advance its neurodegenerative programmes and partnerships in metabolic disease. Dr Venuti was previously CEO of BioSeek, which was acquired by Asterand earlier this month.